Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gyuri Kim

Showing results (191-200 of 194) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 194 results.
Diabetes, Obesity & Metabolism|April 23, 2020
Efficacy and safety of evogliptin treatment in patients with type 2 diabetes: A multicentre, active-controlled, randomized, double-blind study with open-label extension (the EVERGREEN study)Gyuri Kim, Soo Lim, Hyuk-Sang Kwon, et al.
Free Radical Biology & Medicine|September 17, 2016
Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitisDa Hyun Lee, Dai Hoon Han, Ki Taek Nam, et al.
Nature Methods|September 18, 2023
Statistically unbiased prediction enables accurate denoising of voltage imaging dataMinho Eom, Seungjae Han, Pojeong Park, et al.
Endocrinology and Metabolism (Seoul, Korea)|July 4, 2020
Diagnosis and Treatment of Growth Hormone Deficiency: A Position Statement from Korean Endocrine Society and Korean Society of Pediatric EndocrinologyJung Hee Kim, Hyun Wook Chae, Sang Ouk Chin, et al.
Pageof 20

Showing results (191-200 of 194) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 194 results.
Diabetes, Obesity & Metabolism|April 23, 2020
Efficacy and safety of evogliptin treatment in patients with type 2 diabetes: A multicentre, active-controlled, randomized, double-blind study with open-label extension (the EVERGREEN study)Gyuri Kim, Soo Lim, Hyuk-Sang Kwon, et al.
Free Radical Biology & Medicine|September 17, 2016
Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitisDa Hyun Lee, Dai Hoon Han, Ki Taek Nam, et al.
Nature Methods|September 18, 2023
Statistically unbiased prediction enables accurate denoising of voltage imaging dataMinho Eom, Seungjae Han, Pojeong Park, et al.
Endocrinology and Metabolism (Seoul, Korea)|July 4, 2020
Diagnosis and Treatment of Growth Hormone Deficiency: A Position Statement from Korean Endocrine Society and Korean Society of Pediatric EndocrinologyJung Hee Kim, Hyun Wook Chae, Sang Ouk Chin, et al.
Pageof 20